Motor neurone disease د.رشاد عبدالغني

Embed Size (px)

Citation preview

  • 8/3/2019 Motor neurone disease .

    1/18

    Motor neurone disease

    The various forms of adult motor neurone diseaseare classified according to the distribution of the

    initial clinical features

  • 8/3/2019 Motor neurone disease .

    2/18

    The clinical findings are the consequence of motor neurone

    loss in the cortex, brain stem and spinal cord, along withdegeneration in the corticobulbar and corticospinal pathways.

    Pathology

  • 8/3/2019 Motor neurone disease .

    3/18

    In progressive muscular atrophy

    Weakness and wasting of the small hand muscles begin

    asymmetrically then extend more uniformly over severalyears. Reflexes are relatively preserved, despite the wasting,

    and fasciculation is prominent. Initial involvement of the

    lower limbs is less common, presenting usually with foot drop

    or wasting of one or both thighs.

  • 8/3/2019 Motor neurone disease .

    4/18

    The spinal muscular atrophies (SMAs)

    They differ in age at onset and severity of

    symptoms.

    SMA type I (severe form): Onset is from birth to 6

    months. Children are never able to sit without support, and

    death usually occurs before the age of 2 years.SMA type II (intermediate form): Onset is before the age

    of 18 months. Children are unable to stand or walk without

    aid, and death usually occurs after the age of 2 years.

    SMA type III (mild form): Onset is after the age of 18

    months. Patients have the ability to stand and walk, and

    death occurs in adulthood.

  • 8/3/2019 Motor neurone disease .

    5/18

    Primary lateral sclerosis is rare. Here there is a

    slowly progressive spastic paraparesis with or

    without upper limb involvement and without motorneurone loss.

    In amyotrophic lateral sclerosis, there is a

    combination of spasticity and hyperreflexia in thelower limbs with weakness, wasting and

    fasciculation in the upper limbs. Later in the illness

    truncal and oropharyngeal muscles are affected.

  • 8/3/2019 Motor neurone disease .

    6/18

  • 8/3/2019 Motor neurone disease .

    7/18

    Progressive bulbar palsy presents with dysphagia and

    dysarthria. The facial muscles atrophy, speech becomes

    slurred and aspiration is likely. Weakness and wasting of the

    tongue become conspicuous, accompanied by fasciculationand slowing of movement.

    include sensory impairment, sphincter

    disorders and ocular involvement.

    Exclusion criteria

  • 8/3/2019 Motor neurone disease .

    8/18

    Lab studies

    EMG studies are of considerable value indiagnosis. A combination of fibrillation and

    fasciculation potentials with large, prolonged

    motor unit potentials is particularly characteristic

  • 8/3/2019 Motor neurone disease .

    9/18

    Muscle biopsy shows the changes of chronic

    denervation with grouped fibre atrophy and fibre-

    type grouping without evidence of inflammatorycell infiltration

    Normal muscle contain

    random checkerboard-like appearance

    Fibre-type grouping

    http://www.emedicine.com/cgi-bin/foxweb.exe/makezoom@/em/makezoom?picture=/websites/emedicine/neuro/images/Large/527518ried11.jpg&template=izoom2
  • 8/3/2019 Motor neurone disease .

    10/18

    Medical care in ALS is primarily palliative.

    Patients should be involved in regular exercise

    and a physical therapy program.

    Medications such as baclofen and tizanidinemay be used to relieve severe spasticity.

    Riluzole, a glutamate inhibitor, is an FDA-

    approved medication for prolongingtracheostomy-free survival.

    Treatment:

  • 8/3/2019 Motor neurone disease .

    11/18

    Syringomyelia

    In syringomyelia cystic cavitation of the spinal cord occurs,

    most prominently in the cervical region sometimes inassociation with cystic cavitation in the brain stem

    (syringobulbia).

  • 8/3/2019 Motor neurone disease .

    12/18

    Causes:

    The condition closely coexists with a number of

    developmental anomalies close to the cervicocranial

    junction, including abnormal fusion of the cervical

    vertebrae, Type 1 Chiari malformation.

    Syringomyelia may also appear in relationship to anintramedullary tumour, and as a post-traumatic

    phenomenon.

  • 8/3/2019 Motor neurone disease .

    13/18

    Clinical features

    There is prominent dissociated anaesthesia in the cervicaldermatomes, often leading to injuries to the hands.

  • 8/3/2019 Motor neurone disease .

    14/18

    Later, touch and proprioceptive function may be affected.

    The motor involvement includes weakness then wastingin upper limb muscles and a spastic paraparesis.

  • 8/3/2019 Motor neurone disease .

    15/18

    The upper limb reflexes become depressed, the lower limb

    reflexes exaggerated. Autonomic dysfunction occurs and

    includes a Horners syndrome, altered sweating of the face

    and arms, and sphincter disturbance. Kyphoscoliosis is

    sometimes found.

  • 8/3/2019 Motor neurone disease .

    16/18

    Investigation

    CT myelography can demonstrate expanded cord and

    delayed opacification of the syringomyelic cavity

  • 8/3/2019 Motor neurone disease .

    17/18

    MRIis the procedure of choice,being more accurate in delineating

    the extent of cavitation and thecerebellar herniation

    Cavity

  • 8/3/2019 Motor neurone disease .

    18/18

    Various forms of surgical treatment have been used

    including: foramen magnum decompression and

    syringoperitoneal or subarachnoid shunting.

    Treatment